Loveworld Medical Centre (LMC) is poised to transform the healthcare landscape with its newly established state-of-the-art nuclear medicine facilities. This bold move, announced at the International Loveworld Medical Symposium on Radionuclide Therapy and Oncology, is set to significantly reduce the need for medical tourism by providing world-class care domestically.
Nuclear medicine, which leverages radioactive substances for both diagnosis and treatment, is a central focus for LMC. Dr. Anthony Oseghale, Chief Operating Officer, highlighted the centre’s commitment to delivering top-tier medical care in Nigeria. “Imagine the costs associated with traveling abroad for medical treatment—flights, accommodation, and more,” Dr. Oseghale said. “Our advanced technology enables Nigerians to access the same level of sophisticated care right here at home, without the added expenses of international travel.”
At the symposium, LMC introduced its latest technological advancement: the Gamma Camera. This pivotal tool in nuclear medicine is expected to enhance both diagnostic and therapeutic capabilities, marking a significant step forward for healthcare in Nigeria. “Over the past six months, our focus has been on refining our processes rather than on publicity,” Dr. Oseghale noted. “Our results and the satisfaction of our patients speak volumes about the quality of care we provide.”
Dr. Oseghale emphasized LMC’s vision to lead the healthcare sector through innovation and comprehensive service. “Our mission is to offer compassionate care through advanced technology and a multidisciplinary approach. We aim to provide accurate diagnoses and holistic medical services under one roof,” he explained. LMC’s partnerships with Health Maintenance Organisations (HMOs), such as Lifesaver HMO, extend affordable and high-quality care, thereby reducing the necessity for medical tourism.
Dr. Emeka Eze, Clinical Director, praised nuclear medicine for its innovative approach, cost-effectiveness, and minimal side effects compared to traditional treatments. “Unlike conventional chemotherapy, which affects all rapidly dividing cells, nuclear medicine specifically targets damaged or inflamed cells, minimizing side effects, hospital stays, and overall treatment costs,” Dr. Eze said. He highlighted the effectiveness of nuclear medicine in treating thyroid diseases, cancers, and arthritis, noting, “This treatment is a game-changer for conditions like arthritis, which is becoming increasingly prevalent among Nigerians due to lifestyle changes and obesity.”
Dr. Deola Phillips, Executive Chairman, concluded the symposium by reaffirming LMC’s dedication to advancing radionuclide therapy. “Our state-of-the-art diagnostic imaging and personalized treatment plans are designed to meet the unique needs of each patient,” Dr. Phillips said. “We are committed to providing exceptional, tailored care through innovation and technology.”
Inspired by the vision of Rev. Chris Oyakhilome, President of Loveworld Inc., LMC continues to expand its capabilities to meet evolving healthcare needs. “Our goal is to deliver advanced, trusted, and comprehensive care close to home,” Dr. Phillips stated. “With these new advancements, Loveworld Medical Centre is well-positioned to make a significant impact on healthcare, offering hope to patients battling various conditions.”
With these developments, Loveworld Medical Centre is set to be a leader in the Nigerian healthcare sector, providing innovative solutions and high-quality care for a broad range of medical conditions.
